Copyright
©The Author(s) 2019.
World J Gastroenterol. Oct 7, 2019; 25(37): 5676-5686
Published online Oct 7, 2019. doi: 10.3748/wjg.v25.i37.5676
Published online Oct 7, 2019. doi: 10.3748/wjg.v25.i37.5676
Table 2 Correlation between disease-related factors and nonalcoholic fatty liver disease on univariate analysis
| Variables, n (%) | NAFLD | Univariate analysis | ||
| Yes | No | Odds ratio (95%CI) | P value | |
| Sex (Male) | 51 (52) | 46 (48) | 3.17 (1.67-5.99) | 0.0005 |
| Smoke | 12 (35) | 23 (65) | 0.69 (0.32-1.51) | 0.36 |
| Disease related factors | ||||
| Disease activity | ||||
| MAYO | 11 (30) | 24 (70) | 0.62 (0.26-1.50) | 0.20 |
| CDAI | 6 (54) | 5 (46) | 1.70 (0.47-6.09) | 0.31 |
| Extraintestinal manifestations | 20 (40) | 31 (60) | 0.97(0.50-1.90) | 0.94 |
| Extended disease | 47 (41) | 66 (59) | 1.14 (0.61-2.13) | 0.68 |
| Disease duration | ||||
| > 10 yr | 35 (42) | 48 (58) | 1.00 Rif. | |
| < 10 yr | 36 (38) | 58 (62) | 1.17 (0.64-2.14) | 0.35 |
| Steroids | 12 (27) | 31 (73) | 0.49 (0.23-1.03) | 0.06 |
| Immunomodulators | 11 (43) | 15 (53) | 1.11 (0.48-2.58) | 0.80 |
| Biologic therapy | 28 (37) | 49 (63) | 0.78 (0.42-1.43) | 0.41 |
| Surgery | 11 (31) | 24 (69) | 0.63 (0.28-1.38) | 0.24 |
| Fecal calprotectin (mg/kg) | ||||
| > 200 | 29 (40) | 44 (60) | 1.00 Rif. | |
| < 200 | 19 (20) | 44 (45) | 1.53 (0.75-3.12) | 0.24 |
| CRP (mg/L, high levels) | 30 (36) | 53 (64) | 0.72 (0.39-1.33) | 0.18 |
- Citation: Magrì S, Paduano D, Chicco F, Cingolani A, Farris C, Delogu G, Tumbarello F, Lai M, Melis A, Casula L, Fantini MC, Usai P. Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history. World J Gastroenterol 2019; 25(37): 5676-5686
- URL: https://www.wjgnet.com/1007-9327/full/v25/i37/5676.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i37.5676